Fetal MMP2/MMP9 polymorphisms and intrauterine growth restriction risk

Journal of Reproductive Immunology

Volumn 74, Issue 1-2, 2007, Pages 143-151

  Gremlich, Sandrine ^a   Nguyen, Daniel ^b   Reymondin, Danielle ^a   Hohlfeld, Patrick ^a   Vial, Yvan ^a   Witkin, Steven S ^b   Gerber, Stefan ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Intrauterine growth restriction; Matrix metalloproteinase; MMP2; MMP9; Polymorphism

Indexed keywords

ADULT; AMNION FLUID; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENZYME ANALYSIS; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOTYPE; GESTATION PERIOD; GESTATIONAL AGE; HUMAN; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MUTATION RATE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; FEMALE; FETAL GROWTH RETARDATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LOGISTIC MODELS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY; RISK FACTORS;

EID: 34247622212     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jri.2007.02.001     Document Type: Article

References (28)

1. Campbell S., Rowe J., Jackson C.J., and Gallery E.D. In vitro migration of cytotrophoblasts through a decidual endothelial cell monolayer: the role of matrix metalloproteinases. Placenta 24 (2003) 306-315
2. Curry Jr. T.E., and Osteen K.G. The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle. Endocr. Rev. 24 (2003) 428-465
3. Dubois B., Masure S., Hurtenbach U., Paemen L., Heremans H., van den Oord J., Sciot R., Meinhardt T., Hammerling G., Opdenakker G., and Arnold B. Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions. J. Clin. Invest. 104 (1999) 1507-1515
4. Dubois B., Arnold B., and Opdenakker G. Gelatinase B deficiency impairs reproduction. J. Clin. Invest. 106 (2000) 627-628
5. Ferrand P.E., Parry S., Samme L.M., Macones G.A., Kuivaniemi H., Romero R., and Strauss III J.F. A polymorphism in the matrix metalloproteinase-9 promoter is associated with increased risk of preterm premature rupture of membranes in African Americans. Mol. Hum. Reprod. 8 (2002) 494-501
6. Galan H.L., Ferrazzi E., and Hobbins J.C. Intrauterine growth restriction (IUGR): biometric and Doppler assessment. Prenat. Diagn. 22 (2002) 331-337
7. Genc M.R., Gerber S., Nesin M., and Witkin S.S. Polymorphism in the interleukin-1 gene complex and spontaneous preterm delivery. Am. J. Obstet. Gynecol. 187 (2002) 157-163
8. Hirano K., Sakamoto T., Uchida Y., Morishima Y., Masuyama K., Ishii Y., Nomura A., Ohtsuka M., and Sekizawa K. Tissue inhibitor of metalloproteinases-2 gene polymorphisms in chronic obstructive pulmonary disease. Eur. Respir. J. 18 (2001) 748-752
9. Hohlfeld P., Marty F., De Grandi P., Tissot J.-D., Bossart H., and Gerber S. Obstétrique. Le Livre De l'Interne. 3rd ed. (2004), Flammarion Médecine-Sciences, Paris, France
10. Itoh T., Ikeda T., Gomi H., Nakao S., Suzuki T., and Itohara S. Unaltered secretion of beta-amyloid precursor protein in gelatinase A (matrix metalloproteinase 2)-deficient mice. J. Biol. Chem. 272 (1997) 22389-22392
11. Joos L., He J.Q., Shepherdson M.B., Connett J.E., Anthonisen N.R., Pare P.D., and Sandford A.J. The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function. Hum. Mol. Genet. 11 (2002) 569-576
12. Kalish R.B., Vardhana S., Gupta M., Perni S.C., and Witkin S.S. Interleukin-4 and -10 gene polymorphisms and spontaneous preterm birth in multifetal gestations. Am. J. Obstet. Gynecol. 190 (2004) 702-706
13. Kim J.S., Park H.Y., Kwon J.H., Im E.K., Choi D.H., Jang Y.S., and Cho S.Y. The roles of stromelysin-1 and the gelatinase B gene polymorphism in stable angina. Yonsei Med. J. 43 (2002) 473-481
14. Lamblin N., Bauters C., Hermant X., Lablanche J.M., Helbecque N., and Amouyel P. Polymorphisms in the promoter regions of MMP-2, MMP-3, MMP-9 and MMP-12 genes as determinants of aneurysmal coronary artery disease. J. Am. Coll. Cardiol. 40 (2002) 43-48
15. Lose F., Thompson P.J., Duffy D., Stewart G.A., and Kedda M.A. A novel tissue inhibitor of metalloproteinase-1 (TIMP-1) polymorphism associated with asthma in Australian women. Thorax 60 (2005) 623-628
16. Maeda S., Haneda M., Guo B., Koya D., Hayashi K., Sugimoto T., Isshiki K., Yasuda H., Kashiwagi A., and Kikkawa R. Dinucleotide repeat polymorphism of matrix metalloproteinase-9 gene is associated with diabetic nephropathy. Kidney Int. 60 (2001) 1428-1434
17. Miao X., Yu C., Tan W., Xiong P., Liang G., Lu W., and Lin D. A functional polymorphism in the matrix metalloproteinase-2 gene promoter (-1306C/T) is associated with risk of development but not metastasis of gastric cardia adenocarcinoma. Cancer Res. 63 (2003) 3987-3990
18. Ogata T., Shibamura H., Tromp G., Sinha M., Goddard K.A.B., Sakalihasan N., Limet R., MacKean G.L., Arthur C., Sueda T., Land S., and Kuivaniemi H. Genetic analysis of polymorphisms in biologically relevant candidate genes in patients with abdominal aortic aneurysms. J. Vasc. Surg. 41 (2005) 1036-1042
19. Peters D.G., Kassam A., St Jean P.L., Yonas H., and Ferrell R.E. Functional polymorphism in the matrix metalloproteinase-9 promoter as a potential risk factor for intracranial aneurysm. Stroke 30 (1999) 2612-2616
20. Polette M., Nawrocki B., Pintiaux A., Massenat C., Maquoi E., Volders L., Schaaps J.P., Birembaut P., and Foidart J.M. Expression of gelatinases A and B and their tissue inhibitors by cells of early and term human placenta and gestational endometrium. Lab. Invest. 71 (1994) 838-846
21. Price S.J., Greaves D.R., and Watkins H. Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation. J. Biol. Chem. 276 (2001) 7549-7558
22. Reis F.M., D'Antona D., and Petraglia F. Predictive value of hormone measurements in maternal and fetal complications of pregnancy. Endocr. Rev. 23 (2002) 230-257
23. Shimajiri S., Arima N., Tanimoto A., Murata Y., Hamada T., Wang K.Y., and Sasaguri Y. Shortened microsatellite d(CA)21 sequence down-regulates promoter activity of matrix metalloproteinase 9 gene. FEBS Lett. 455 (1999) 70-74
24. Vu T.H., Shipley J.M., Bergers G., Berger J.E., Helms J.A., Hanahan D., Shapiro S.D., Senior R.M., and Werb Z. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93 (1998) 411-422
25. Witkin S.S., Vardhana S., Yih M., Doh K., Bongiovanni A.M., and Gerber S. Polymorphism in intron 2 of the fetal interleukin-1 receptor antagonist genotype influences midtrimester amniotic fluid concentrations of interleukin-1beta and interleukin-1 receptor antagonist and pregnancy outcome. Am. J. Obstet. Gynecol. 189 (2003) 1413-1417
26. Xu P., Wang Y.L., Zhu S.J., Luo S.Y., Piao Y.S., and Zhuang L.Z. Expression of matrix metalloproteinase-2, -9, and -14, tissue inhibitors of metalloproteinase-1, and matrix proteins in human placenta during the first trimester. Biol. Reprod. 62 (2000) 988-994
27. Ye S. Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases. Matrix Biol. 19 (2000) 623-629
28. Yu C., Pan K., Xing D., Liang G., Tan W., Zhang L., and Lin D. Correlation between a single nucleotide polymorphism in the matrix metalloproteinase-2 promoter and risk of lung cancer. Cancer Res. 62 (2002) 6430-6433